There is no difference in the disease severity of gastro‐oesophageal reflux disease between patients infected and not infected with Helicobacter pylori

@article{Fallone2004ThereIN,
  title={There is no difference in the disease severity of gastro‐oesophageal reflux disease between patients infected and not infected with Helicobacter pylori},
  author={C. Fallone and A. Barkun and S. Mayrand and G. Wakil and G. Friedman and A. Szilagyi and C. Wheeler and D. Ross},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2004},
  volume={20}
}
Background : The role of Helicobacter pylori in gastro‐oesophageal reflux disease (GERD) is controversial. 
Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis
TLDR
The majority of gastro‐oesophageal reflux disease (GERD) seems to be non‐erosive Reflux disease, which includes minimal change oesophagitis and erosion that is not regarded as mucosal break. Expand
Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship.
  • R. Souza, J. H. Lima
  • Medicine
  • Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
  • 2009
TLDR
This review discusses the pathophysiological and immunological mechanisms implicated in the relationship between gastroesophageal reflux disease and Helicobacter pylori and clarify how the host's immune response and bacterial virulence factors interfere with this relationship. Expand
Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.
TLDR
It is suggested that lansoprazole 15 mg/day is an effective treatment in the control of NERD symptoms, that it may be a good initial therapeutic strategy, and that, according to data available, H. pylori infection has no significant effect on the response to treatment. Expand
Effect of Helicobacter pylori eradication on reflux esophagitis and GERD symptoms after endoscopic resection of gastric neoplasm: a single-center prospective study
TLDR
H. pylori eradication did not increase the incidence of RE or GERD symptoms in patients who underwent endoscopic resection of gastric neoplasm, and present smoking history and diabetes mellitus were found to be associated with RE. Expand
Helicobacter pylori and Non‐malignant Diseases
TLDR
H. pylori eradication is of value in chronic NSAID users, but is insufficient to prevent NSAID‐related ulcer disease. Expand
Helicobacter Pylori Infection Is Protective Against Development Of Complications Of Gastro Esophageal Reflux Disease (GERD): A Study Done In Central Gujarat.
TLDR
Investigation of the prevalence and association of H. pylori and its virulent strain in patients with gastro esophageal reflux disease and its correlation with various clinical, endoscopic and demographic parameters shows that absence of hiatal hernia is associated with Gastro esophagesia reflux Disease. Expand
Helicobacter pylori and gastroesophageal reflux disease
TLDR
Gastric atrophy is the most widely accepted mechanism by which the distal esophagus is protected from abnormal acid exposure in patients with H. pylori infection. Expand
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
TLDR
Whether to test for H. pylori in patients with functional dyspepsia, gastroesophageal reflux disease (GERD), patients taking nonsteroidal antiinflammatory drugs, with iron deficiency anemia, or who are at greater risk of developing gastric cancer remains controversial. Expand
Effect of Helicobacter pylori Eradication on Reflux Esophagitis Therapy: A Multi-center Randomized Control Study
TLDR
Based on esomeprazole therapy, H. pylori infection and eradication have no significant effect on reflux esophagitis therapy. Expand
DIAGNOSIS AND TREATMENT OF HELICOBACTER PYLORI INFECTION : A REVIEW
Helicobacter pylori remain a prevalent, worldwide, chronic infection. Though the prevalence of this infection appears to be decreasing in many parts of the world, H. pylori remains an importantExpand
...
1
2
3
...

References

SHOWING 1-10 OF 53 REFERENCES
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non‐erosive gastro‐oesophageal reflux disease
TLDR
The majority of reflux patients have non‐erosive reflux disease, and 90% of patients diagnosed with reflux have atypical EGFRs, according to the World Health Organization. Expand
Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme
TLDR
It is shown that Helicobacter pylori infection has been proposed as a protective factor against the development of gastro‐oesophageal reflux disease and is associated with good prognosis in women. Expand
The effect of Helicobacter pylori eradication on gastro‐oesophageal reflux
TLDR
It is hypothesized that H.’pylori eradication might increase gastro‐oesophageal acid reflux in patients with reflux oesophagitis. Expand
Recurrent symptoms and gastro‐oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection
TLDR
Eradication of Helicobacter pylori has been shown to prevent relapse of endoscopically detected duodenal ulcers and gastro‐oesophageal reflux disease (GERD) may develop as a result of H.’pylori eradication. Expand
Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride
TLDR
There are no comparative data in this respect for acid pump inhibitors and prokinetic agents in relation to gastro‐oesophageal reflux disease, but the use of these agents in combination with each other to treat this disease is suggested to be beneficial. Expand
Helicobacter pylori and non-ulcer dyspepsia — a critical look
The question of whether Helicobacter pylori plays a role in non-ulcer dyspepsia (NUD) remains one of the most important unresolved clinical questions of 1998. Several review articles have beenExpand
Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease.
  • K. Ishiki, M. Mizuno, +7 authors Y. Shiratori
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2004
TLDR
In patients with reflux esophagitis associated with duodenal ulcer, a significant improvement in pre-existing reflux eosinophilia was noted after H. pylori eradication. Expand
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study
TLDR
The prevalence of clinically significant upper gastrointestinal findings in adult uninvestigated dyspepsia patients, and their predictability based on history, is unknown. Expand
Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease
TLDR
A substantial proportion of ulcer patients have symptoms and/or signs of coexisting gastroesophageal reflux disease (GERD) at initial presentation and this reduces the symptomatic benefit from H. pylori eradication, and there is no evidence that eradicating H.pylori induces de novo GERD symptoms in ulcers patients. Expand
Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies
TLDR
The results do not support the hypothesis that H. pylori eradication in patients with duodenal ulcer disease leads to the development of erosive esophagitis, the development Of gastroesophageal reflux disease (GERD) symptoms in patients without prior symptomatic or endoscopic GERD, or worsening of symptoms in Patients with pre-existing GERD. Expand
...
1
2
3
4
5
...